Navigation Links
Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System
Date:7/12/2011

n to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking statements contained in this document.CONTACT:

Erik Kopp508-650-8660 (office)Media RelationsBoston Scientific Corporationerik.kopp@bsci.comSean Wirtjes508-652-5305 (office)Investor RelationsBoston Scientific Corporationinvestor_relations@bsci.com
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  Asterias Biotherapeutics, ... on the emerging field of regenerative medicine, today ... at Chicago -based Rush University ... evaluating activity of escalating doses of AST-OPC1 (oligodendrocyte ... and motor complete cervical spinal cord injury (SCI). ...
(Date:8/31/2015)... Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company ... for the treatment of diseases of the central nervous ... IND submission has passed review by the US Food ... Phase 1 clinical trial in patients with metastatic colon ... to 31 December 2015. Bionomics, CEO & ...
(Date:8/30/2015)... LONDRES, August 30, 2015 ... de l cuidado al paciente ... trayecto   Royal Philips  (NYSE: ... de IntelliSpace Cardiovascular , un sistema web de ... para acceder, analizar y compartir imágenes cardiovasculares e información ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
... Nycomed US Inc. announced today the appointment of Joseph ... General Counsel, reporting to Steve Andrzejewski, CEO of Nycomed ... the company and oversee all of the company,s legal ... be responsible for the company,s compliance functions.   ...
... RICHMOND, Va., Nov. 10, 2010 Filtrona Porous ... grade foam and fiber components designed to absorb, ... will display an expanded range of polyurethane foams ... trade fair in Dusseldorf, Germany from 17 to ...
Cached Medicine Technology:Joseph J. LaRosa Joins Nycomed US Inc. 2
(Date:8/31/2015)... ... August 31, 2015 , ... ... communications company announced today that it has officially launched a new website and ... website and brand refresh are more closely aligned with the company’s strategic vision ...
(Date:8/31/2015)... ... ... dental implant and prosthetic market in the U.S. is projected to reach $6.4 billion ... More than 30 million Americans are missing all their teeth in one or both ... National Association of Dental Laboratories (NADL) created the “What’s In Your Mouth?” campaign to ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad ... a ribbon-cutting ceremony on Aug. 26, generously hosted by the Collinsville Chamber of ... via AdvantaClean’s National Call Center and website since Aug. 17. , The Greens ...
(Date:8/31/2015)... ... ... Finnleo , a leader in the sauna industry, is pleased to announce ... re-styled and re-designed “Hallmark Series” updates the Passport series with a feature rich, portable ... and a more upscale feel than the current Passport a beautiful 6-bar two-toned curved ...
(Date:8/31/2015)... ... 31, 2015 , ... Physicians’ Education Resource®, LLC (PER®) ... Innovative Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for its ... City. The annual legacy meeting uses a variety of formats to educate all ...
Breaking Medicine News(10 mins):Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:Finnleo Introduces Hallmark Series Saunas 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4
... Mayo Clinic researchers have discovered two mutations responsible for ... ago. The researchers say their study -- appearing in ... neural pathway that may help understand a variety of ... now because of Next Generation genomic sequencing technology," says ...
... , SATURDAY, April 30 (HealthDay News) -- After reviewing ... up to age 3, researchers found that about 4 percent ... higher among the youngest babies, the study found. "Almost ... 2 months, received more than twice the dose that they ...
... SUNDAY, May 1 (HealthDay News) -- Increased bursts of sleep in ... new study included 23 parents who kept daily sleep records for ... at the start of the study. The researchers analyzed the total ... The infants had uneven bursts of sleep, with the amount ...
... at extremely low levels, is associated with increased blood pressure ... 1, at the Pediatric Academic Societies (PAS) annual meeting in ... increased risk of having high blood pressure, or hypertension, as ... and kidney disease and is the third leading contributor to ...
... parent or caregiver to look in the rearview mirror while ... of their safety restraints. A study on child self-unbuckling by ... first unbuckle were age three and under and that many ... a 3.5-fold increased risk for serious injuries. , "We found ...
... study in the May 1 issue of the journal Sleep ... among infants are significantly associated with growth spurts in body length. ... 24-hour sleep duration increasing at irregular intervals by an average of ... sleep episodes per day also increased in intermittent bursts of an ...
Cached Medicine News:Health News:Mayo Clinic finds new genetic cause of neurodegeneration 2Health News:Young Kids' Prescriptions Not Always on the Mark 2Health News:Extra Sleep in Infants Seems to Signal Growth Spurts 2Health News:Living with a smoker may raise blood pressure in boys 2Health News:Little fingers, big trouble: Yale study sheds light on child self-unbuckling 2Health News:Study is the first to link sleep duration to infant growth spurts 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: